Revive (RVVTF) Hits a Snag?

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 First our summary."FDA provided communication that...
Dr John Fahy UCSF

Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...

What is NAC (N-Acetyl-L-Cysteine)? (Dr Eric Berg)

https://youtu.be/oPdGOrqTfhA What is NAC good for? (and How Much to Take?)

FDA Issues Final ‘Enforcement Discretion’ Guidance on NAC.

NAC Crosses Major Hurdle With FDA. Is Bucillamine Next. Josh Long | Aug 01, 2022 "Industry, and...

Revive Therapeutics (RVVTF) Enters the Danger Zone.

What Danger You Ask? Danger #1, the FDA doesn't like the data, and you own the stock.

Revive’s Quarterly Report, Discussion, and a Video!

With 5,000 hospitalizations reported daily (150,000 a month), contracting Covid is not something to be taken lightly - after you get it....
Revive Therapeutics

Revive Therapeutics Gains 25% on Positive FDA Comments.

The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and...

Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?

Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found...
Revive Therapeutics

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...

Two Binary Events Directly Ahead. As in Months Away, not Years. Share Price up 76% During April.

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...

New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.

Latest article

Adding Asia Broadband (AABB) to WatchList.

Gold Backed Cryptocurrency Token. Adding Asia Broadband (AABB) $0.028 to the Watch List.

Adding Terran Orbital (LLAP) $1.15 to Watch List. Risk Arbitrage Idea.

Lockheed Martin (LMT) Offers $1.00 Per Share to Acquire Terran Orbital. LIVE QUOTE

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so...